The present invention makes available prodrugs of 9.alpha.-substituted oestratrienes of the general formula (I) in which the group Z is bonded to the steroid, processes for their preparation, pharmaceutical compositions which comprise these compounds and use thereof. The compounds of the general formula I according to the invention do not bind to the oestrogen receptor a and/or .beta.. They bind to carboanhydrases and inhibit these enzymes.